When Your Gut Produces GABA, Sleep Changes: The Lp815 RCT

If magnesium or melatonin haven’t moved the needle on your sleep, there may be a different pathway worth considering. A randomized, double-blind, placebo-controlled trial published in Scientific Reports in January 2026 found that a GABA-producing probiotic strain improved sleep and anxiety measures in six weeks. Among women specifically, the response rate was 100%.

What It Means for Your Gut to Produce GABA

GABA (gamma-aminobutyric acid) is the brain’s primary inhibitory neurotransmitter. Most sleep aids and anti-anxiety medications work by targeting GABA receptors. What’s less commonly known is that GABA isn’t only made in the brain. Certain gut bacteria synthesize GABA directly, and evidence suggests this gut-produced GABA signals the central nervous system via the vagus nerve.

Lactiplantibacillus plantarum Lp815 was developed specifically for this pathway. Researchers screened more than 250 million microbial variants to identify the strain with the highest GABA production capacity in the gut. This is why strain specificity matters so much: two strains with the same genus name can work completely differently depending on their genetic makeup.

The Numbers from Six Weeks

Participants were 138 adults with moderate-to-severe sleep disturbance (average age 44, 51% women). Half received 5 billion CFU of Lp815 daily; the other half received a matching placebo. All participants wore an Oura Ring for objective sleep tracking and completed validated questionnaires including the Insomnia Severity Index (ISI) and the Generalized Anxiety Disorder 7-item scale (GAD-7).

Sleep improvement (defined as at least 4-point improvement on ISI)

• Lp815 group: 77.3%
• Placebo group: under 58%
• Women participants only: 100%

Anxiety reduction

• GAD-7 scores decreased significantly in the Lp815 group vs. placebo at six weeks (p<0.05)
• Women showed greater effects (p<0.01)

Night sweats

• 40% of participants reported reduced severity

Oura Ring objective data

• Increases in total sleep duration and deep sleep duration
• Reduced sleep latency confirmed

The timeline was also specific. Urinary GABA levels rose significantly above placebo within the first week (p<0.05) and remained elevated through week six. Sleep improvements began in week one. Perceived stress reduction became noticeable in self-reports by week two. No gastrointestinal side effects were reported.

The GABA-Sleep-Anxiety Connection

The rapid rise in urinary GABA provides direct evidence that Lp815 is producing GABA in the gut. More importantly, urinary GABA levels at week two were inversely correlated with ISI and GAD-7 scores, meaning the more GABA was produced, the lower the insomnia and anxiety scores.

The question of how gut-produced GABA influences the brain when it cannot cross the blood-brain barrier is still under active research. The leading hypothesis involves the vagus nerve. When GABA signals reach intestinal epithelial cells, inhibitory signals travel through the vagus nerve to the brainstem and limbic system, quieting the system without GABA ever entering circulation.

Why Women Responded at 100%

This is one of the most notable figures from the trial. The researchers point to the relationship between estrogen and GABA receptor sensitivity as a possible explanation. Estrogen modulates GABA receptor function, and during periods of hormonal fluctuation such as the premenstrual window or perimenopause, the GABA system becomes more reactive.

For women whose sleep disruptions worsen in the week before a period, or who have noticed increasing nighttime waking in their mid-30s without a clear cause, the estrogen-GABA connection may be part of the story.

How This Differs from Earlier Psychobiotic Research

Previous research on psychobiotics has largely focused on multi-strain formulations or broad reviews of available data. The Lp815 trial stands out as a single-strain, mechanistically grounded RCT. The data shows which strain, via which mechanism, produced which outcomes in which population. That level of specificity is still rare in this category.

The inclusion of objective wearable data alongside self-reported questionnaires also strengthens the methodology. Sleep research that relies entirely on subjective reporting has known limitations; Oura Ring measurements add an independent layer of confirmation.

What to Look for in a Product

If you’re considering trying this approach, the label should specify Lactiplantibacillus plantarum Lp815 by name. The clinical data belongs to this strain. Other Lactiplantibacillus strains, even close relatives, are not interchangeable with these results.

The dose used in the trial was 5 billion CFU (5B CFU) per day. Also check whether the CFU count is guaranteed at the expiration date, not just at the time of manufacture. Probiotic potency can decline during distribution and storage.

If you’re currently taking immunosuppressants or antibiotics, consult your doctor before adding any probiotic to your routine.

The trial’s 138-person scale and single-strain design are acknowledged limitations. But the consistent female response, the GABA-to-outcome correlation pattern, and the Oura Ring confirmation collectively support this direction as a serious area of follow-up research. The gut-brain pathway for sleep isn’t a hypothesis anymore. The question now is which strains work, for whom, and under what conditions.